World's Best Scientists 2026 revealed!
Ralph T. Schermuly

Ralph T. Schermuly

D-Index & Metrics

Medicine

D-Index
96
Citations
34000
World Ranking
9661
National Ranking
535

Overview

Ralph T. Schermuly is affiliated with the University of Giessen in Germany. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a significant focus on pulmonary and respiratory medicine, cardiology and cardiovascular medicine, and molecular biology. Additional subfields include immunology and physiology.

The scientist's work prominently addresses several main topics, including:

  • Pulmonary Hypertension Research and Treatments
  • Neonatal Respiratory Health Research
  • Cardiovascular Function and Risk Factors
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Respiratory Support and Mechanisms
  • Eicosanoids and Hypertension Pharmacology
  • Heart Failure Treatment and Management

Ralph T. Schermuly has published extensively, with notable frequent publication venues such as:

  • American Journal of Respiratory and Critical Care Medicine
  • International Journal of Molecular Sciences
  • Cells
  • European Respiratory Journal
  • Pneumologie

The recent papers produced or contributed to by Schermuly include:

  • "Pulmonary Hypertension in Acute and Chronic High Altitude Maladaptation Disorders," 2021, International Journal of Environmental Research and Public Health
  • "Pathology and pathobiology of pulmonary hypertension: current insights and future directions," 2024, European Respiratory Journal
  • "Targeting Jak-Stat Signaling in Experimental Pulmonary Hypertension," 2020, American Journal of Respiratory Cell and Molecular Biology
  • "Targeting Wnt-ß-Catenin-FOSL Signaling Ameliorates Right Ventricular Remodeling," 2023, Circulation Research
  • "Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19," 2021, Blood Advances

Frequent collaborators in their work include Norbert Weißmann, Werner Seeger, Hossein Ardeschir Ghofrani, Baktybek Kojonazarov, and Friedrich Grimminger. These coauthors have partnered repeatedly, reflecting ongoing research collaborations.

Best Publications

  • Reversal of experimental pulmonary hypertension by PDGF inhibition.

    Ralph Theo Schermuly;Eva Dony;Hossein Ardeschir Ghofrani;Soni Pullamsetti

  • Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives.

    Marc Humbert;Marc Humbert;Christophe Guignabert;Christophe Guignabert;Sébastien Bonnet;Peter Dorfmüller;Peter Dorfmüller

  • Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

    Hossein Ardeschir Ghofrani;Ralph Wiedemann;Frank Rose;Ralph T Schermuly

  • Inflammation, growth factors, and pulmonary vascular remodeling.

    Paul M. Hassoun;Luc Mouthon;Joan A. Barberà;Saadia Eddahibi

  • Mechanisms of disease: pulmonary arterial hypertension

    Ralph T. Schermuly;Hossein A. Ghofrani;Martin R. Wilkins;Friedrich Grimminger

  • Combination Therapy with Oral Sildenafil and Inhaled Iloprost for Severe Pulmonary Hypertension

    Hossein Ardeschir Ghofrani;Ralph Wiedemann;Frank Rose;Horst Olschewski

  • Relevant issues in the pathology and pathobiology of pulmonary hypertension

    Rubin M Tuder;Stephen L Archer;Peter Dorfmüller;Serpil C Erzurum

  • Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.

    Horst Olschewski;Dieter Walmrath;Ralph Schermuly;H. Ardeshir Ghofrani

  • Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension

    Hossein A Ghofrani;Frank Rose;Ralph T Schermuly;Horst Olschewski

  • Inhaled Prostacyclin and Iloprost in Severe Pulmonary Hypertension Secondary to Lung Fibrosis

    Horst Olschewski;H. Ardeschir Ghofrani;Dieter Walmrath;Ralph Schermuly

  • Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome.

    Dieter Walmrath;Thomas Schneider;Ralph Schermuly;Horst Olschewski

  • Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.

    Hossein A. Ghofrani;Robert Voswinckel;Frank Reichenberger;Horst Olschewski

  • Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension.

    Rajkumar Savai;Soni S. Pullamsetti;Julia Kolbe;Ewa Bieniek

  • Sildenafil for Long-Term Treatment of Nonoperable Chronic Thromboembolic Pulmonary Hypertension

    Hossein A. Ghofrani;Ralph T. Schermuly;Frank Rose;Ralph Wiedemann

  • Inducible NOS Inhibition Reverses Tobacco-Smoke-Induced Emphysema and Pulmonary Hypertension in Mice

    Michael Seimetz;Nirmal Parajuli;Alexandra Pichl;Florian Veit

  • Hypoxia-Dependent Regulation of Nonphagocytic NADPH Oxidase Subunit NOX4 in the Pulmonary Vasculature

    Manish Mittal;Markus Roth;Peter König;Simone Hofmann

  • Chronic Sildenafil Treatment Inhibits Monocrotaline-induced Pulmonary Hypertension in Rats

    Ralph T. Schermuly;Klaus P. Kreisselmeier;Hossein A. Ghofrani;Hüseyin Yilmaz

  • Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange.

    Norbert Weissmann;Alexander Dietrich;Beate Fuchs;Hermann Kalwa

  • The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups

    Henning Gall;Janine F. Felix;Franziska K. Schneck;Katrin Milger

  • First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension.

    F. Grimminger;G. Weimann;R. Frey;R. Voswinckel

Frequent Co-Authors

Werner Seeger
Werner Seeger University of Giessen
Norbert Weissmann
Norbert Weissmann University of Giessen
Hossein Ardeschir Ghofrani
Hossein Ardeschir Ghofrani University of Giessen
Friedrich Grimminger
Friedrich Grimminger University of Giessen
Horst Olschewski
Horst Olschewski Medical University of Graz
Ralf P. Brandes
Ralf P. Brandes Goethe University Frankfurt
Saverio Bellusci
Saverio Bellusci University of Giessen
Oliver Eickelberg
Oliver Eickelberg University of Pittsburgh
Walter Klepetko
Walter Klepetko Medical University of Vienna
Stephan Rosenkranz
Stephan Rosenkranz University of Cologne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Thinking about a career in medicine but want more flexibility or alternative pathways? Many health professions now offer online degree programs, opening doors to a range of meaningful careers beyond becoming a doctor.

Nursing remains a popular choice, with pathways like an lpn program without teas test making it easier to start your journey without additional entrance exams. For those interested in healthcare leadership, earning a degree in healthcare administration can unlock roles in hospital management or policy.

Some registered nurses (RNs) may want to advance their careers quickly. Options like adn to fnp bridge programs help RNs move directly from an associate degree to a master’s and become family nurse practitioners (FNP) faster.

For those interested in promoting better health through diet, a bachelor's in nutrition online provides the foundation for careers in nutrition counseling or wellness coaching.

Each of these online degrees offers unique paths into healthcare and can be a smart alternative or complement to a traditional medical degree.

Best Scientists Citing Ralph T. Schermuly

Trending Scientists